Circulating levels of advanced glycation end products in diabetes mellitus-related dementia

Journal of the American Geriatrics Society

Volumn 63, Issue 10, 2015, Pages 2196-2198

  Hirose, Daisuke ^a   Hanyu, Haruo ^a   Fukusawa, Raita ^a   Hatanaka, Hirokuni ^a   Namioka, Nayuta ^a   Okita, Misa ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; CREATININE; PENTOSIDINE;

AGED; ALZHEIMER DISEASE; BRAIN PERFUSION; BRAIN TISSUE; CEREBROSPINAL FLUID; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMENTIA; DIABETES MELLITUS; DIABETES MELLITUS RELATED DEMENTIA; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROTEIN BLOOD LEVEL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BLOOD; COGNITION; COMPLICATION; INTELLIGENCE TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; STATISTICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION; DEMENTIA; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTELLIGENCE TESTS; MALE; STATISTICS AS TOPIC;

EID: 84944589808     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13683     Document Type: Letter

References (10)

1. Biessels GJ, Staekenborg S, Brunner E, et al., Risk of dementia in diabetes mellitus: A systemic review. Lancet Neurol 2006; 5: 64-74.
2. Fukasawa R, Hanyu H, Sato T, et al., Subgroups of Alzheimer's disease associated with diabetes mellitus based on brain imaging. Dement Geriatr Cogn Disord 2013; 35: 280-290.
3. Fukasawa R, Hanyu H, Shimizu S, et al., Identification of diabetes-related dementia: Longitudinal perfusion SPECT and amyloid PET studies. J Neurol Sci 2015; 349: 45-51.
4. Fukasawa R, Hanyu H, Namioka N, et al., Elevated inflammatory markers in diabetes-related dementia. Geriatr Gerontol Int 2014; 14: 229-231.
5. Hanyu H, Hirose D, Fukasawa R, et al., Guidelines for the clinical diagnosis of diabetes mellitus-related dementia. J Am Geriatr Soc 2015; 63: 1721-1723.
6. Girones X, Guimera A, Cruz-Sanchez C-Z, et al., N(epsilon)-carboxymethyllysin in brain aging, diabetes mellitus, and Alzheimer's disease. Free Radic Biol Med 2004; 36: 1241-1247.
7. Valente T, Gella A, Fernandez-Busquets X, et al., Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus. Neurobiol Dis 2010; 37: 67-76.
8. Bar KJ, Franke S, Wenda B, et al., Pentosidine and N(epsilon)-(carboxymethyl)- lysine in Alzheimer's disease and vascular dementia. Neurobiol Aging 2003; 24: 333-338.
9. Shuvaev V, Laffont I, Serot J-M, et al., Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol Aging 2001; 22: 397-402.
10. Meli M, Perier C, Ferron C, et al., Serum pentosidine as an indicator of Alzheimer's disease. J Alzheimer Dis 2002; 4: 93-96.